ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of ...
Abbott Park, Ill.-based Abbott Laboratories and Saint Paul, Minn.-based St. Jude Medical — which Abbott is in the process of acquiring for $25 billion — plan to sell several medical devices to ...
SOMERSET, N.J., Dec. 11, 2023 /PRNewswire/ -- Terumo Medical Corporation is pleased to announce the launch of its new AZUR HydroPack Peripheral Coil System in the United States. The AZUR HydroPack ...
Terumo Corporation’s (TRUMY) wholly-owned subsidiary MicroVention, Inc. recently announced the publication of the Clinical Evaluation of WEB 17 Device in Intracranial Aneurysms (CLEVER) study results.
Terumo is a conglomerate with three distinct divisions: cardiac and vascular, medical care solutions, and blood and cell technologies.
Terumo, a medical device company based in Tokyo, Japan, will acquire Sequent Medical for $280 million, with up to $100 million more to be paid based on achievement of specific development objectives.
I'm Hagimoto, Terumo's CFO. I would like to present an overview of the year-end financial results for the fiscal year ending March 31, 2024. These are the highlights of this year's financial statement ...
Terumo is a conglomerate with three distinct divisions: cardiac and vascular, medical care solutions, and blood and cell technologies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results